Abstract:Background: Systemic lupus erythematosus (SLE) is the prototype of autoimmune disease and is characterized by the production of a variety of autoantibodies. and lupus nephritis continues to be a principal cause of morbidity and mortality.The focus is to finding biomarkers that can monitor renal activity and predict prognosis for early diagnosis and treatment. Complement C1q is the starter molecule of the classical pathway of complement activation and plays an important role in the clearance of immune complexes and apoptotic cell debris. Hereditary homozygous deficiency of C1q has been described to be the strongest risk factor for developing SLE.There are some cross-sectional studies on anti-C1q in which the antibody was found to have a significant association with renal involvement but the association of anti-C1q antibodies (antiC1q) with lupus nephritis (LN) still a matter of debate. Objectives: We assessed the association between lupus nephritis disease activity and anti-C1q antibodies Methods: We retrospectively analyzed the medical records of 88 patients with lupus nephritis, aged 35.7±10.8 years on the average, with SLE of average duration 12 (3, 57) years.In all examines the levels of anti-dsDNA and anti-C1q antibodies were measured using the ELISA, C3, C4, 24-hour urinary protein performed in parallel were reviewed. The Clinical manifestations of SLE was also collected.Lupus nephritis disease activity was measured by The SLICC Renal Activity Score of 2004,All biopsied tissues were scored based on the to ISN/RPS2003 lupus nephritis pathological typing standards,Acute Index,Chronic Index Score were used to evaluated the activities of lupus, All the analyses were performed by SPSS 20.0 software. Results: Patients with active lupus nephritis had a higher levels of anti-C1q antibodies than inactive lupus nephritis (68.9(34.1, 140.1)vs. 11.6(5.5, 44.1); p<0.001)(Figure 1). Anti-C1q antibody levels were positively correlated with levels of 24-hour urinary protein(r=0.605; P=0.000),AI score(r=0.337; P=0.001),and negatively correlated with serum C3(r=-0.573; P=0.000) and C4 (r=-0.509; P=0.000).(Figure2). Figure 2 A: Anti-C1q antibody levels were positively correlated with AI score Figure 2 B: Anti-C1q antibody levels were positively correlated with levels of 24-hour urinary protein Figure2-C:Anti-C1q antibody levels were positively correlated with C3 Figure2-D:Anti-C1q antibody levels were positively correlated with C4 Conclusion: Anti-C1q antibodies are more closely correlated with renal disease activity. References [1] Clarke AE, Panopalis P, Petri M, Manzi S, Isenberg DA, Gordon C, et al. SLE patients with renal damage incur higher health care costs[J]. Rheumatology (Oxford, England). 2008;47(3):329-33. [2] Walport MJ. Complement. First of two parts[J]. N Engl J Med. 2001;344(14):1058. [3] Walport MJ. Complement. Second of two parts[J]. N Engl J Med. 2001;344(15):1140. [4] Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus[J]. Autoimmunity. 2007;40(8):560-6. [5] Akhter E,., Burlingame RW, Seaman AL, Magder L,., Petri M,. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers[J]. Lupus. 2011;20(12):1267-74. Disclosure of Interests: None declared

Circulating anti-C3b IgG in lupus nephritis: A large cohort study

Serum Levels and Renal Deposition of C1q Complement Component and Its Antibodies Reflect Disease Activity of Lupus Nephritis

Anti-C1q Antibodies and IgG Subclass Distribution in Sera from Chinese Patients with Lupus Nephritis.

Detection of Anti-C1q Antibodies and Anti-C1q Globular Head Domain Antibodies in Sera from Chinese Patients with Lupus Nephritis.

Characteristics and Renal Survival of Patients with Lupus Nephritis with Glomerular Immunoglobulin G4 Deposition: a Single-Centre Retrospective Analysis.

Clinical relevance of anti-C3 and anti-C4 autoantibodies in lupus nephritis

SAT0673 ANTI-C1Q ANTIBODIES HAVE HIGHER CORRELATION WITH LUPUS NEPHRITIS DISEASE ACTIVITY

Brief report on the relation between complement C3a and anti dsDNA antibody in systemic lupus erythematosus

Clinical relevance of glomerular IgM deposition in patients with lupus nephritis

Anti-C1q Autoantibodies from Active Lupus Nephritis Patients Could Inhibit the Clearance of Apoptotic Cells and Complement Classical Pathway Activation Mediated by C1q in Vitro.

The study of the association of anti-C1q antibody with disease activity and lupus nephritis in SLE patients

Antibodies Against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis

Complement Alternative Pathway׳s Activation in Patients with Lupus Nephritis.

Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review

Role of Anti-C1q Antibodies as Indicator of Renal Activity in Systemic Lupus Erythematosus

C4d As a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy.

Systemic evaluation of lymphocyte-bound C4d and immunoglobulins for diagnosis and activity monitoring of systemic lupus erythematosus

Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.

Relationship Between Anti-C1q Antibody and Renal Pathology of Lupus Nephritis

Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis

Significance of Peritubular Capillary C4d Deposition in Patients with Lupus Nephritis